Prerequisites
Diagnosis: Establish probable diagnosis of alcohol withdrawal using DSM-5 or ICD-11 . It is crucial to rule out other medical conditions that can mimic withdrawal, such as sepsis, metabolic disturbances, or intracranial events.
BAL (Blood Alcohol Level): While not a contraindication to starting treatment, it is preferable to begin dosing when the BAL is low or falling (e.g., < 0.1 g/dL). This helps differentiate symptoms of intoxication from true withdrawal.
Liver Function: Assess liver function (LFTs, INR, Albumin) to guide benzodiazepine choice. Severe liver impairment may necessitate using a drug with no active metabolites, like Oxazepam.
CIWA-Ar Scale: Commence CIWA-Ar monitoring every 2-4 hours. This objective scale guides symptom-triggered therapy, allowing for tailored dosing and preventing both under- and over-sedation.
Post-withdrawal plan: Ensure there is a follow-up plan in place for ongoing support and monitoring after the withdrawal process. To withdraw without a plan is to risk (1) relapse and broader treatment futility (2) reducing alcohol tolerance and temporarily worsening risks of intoxication.
Thiamine
Prophylaxis (Standard Regimen): To prevent Wernicke's Encephalopathy (WE), all patients undergoing alcohol withdrawal should receive parenteral thiamine. Commence thiamine 300mg IV/IM daily for 3-5 days. Crucially, always administer thiamine BEFORE any glucose-containing fluids.
Suspected Wernicke-Korsakov Syndrome (WKS): Have a high index of suspicion for WKS in any patient with confusion, ataxia, ophthalmoplegia, memory disturbance, or malnutrition. The classic triad is rare. Treatment requires high-dose thiamine: 500mg IV TDS for a minimum of 5 days, followed by oral supplementation.
Caveat: Patients must be magnesium replete for adequate thiamine absorption and activation.
1. Benzodiazepine Choice
Diazepam: The standard choice due to its long half-life, which provides a smooth, self-tapering effect and reduces the risk of breakthrough symptoms and seizures.
Oxazepam: Preferred in specific situations as it has no active metabolites and is less likely to accumulate.
Use Oxazepam in cases of:
• Significant liver impairment (e.g., cirrhosis, high bilirubin, coagulopathy).
• Respiratory insufficiency or risk of respiratory depression (e.g., COPD).
• Elderly or frail patients who are more sensitive to sedative effects.
• Cerebral trauma / CVA where over-sedation is a risk.
Conversion: Diazepam 10mg is approximately equivalent to Oxazepam 30mg.
Current Selection: Diazepam
2. Regimens (CIWA-Ar)
Displaying Regimens for: Diazepam
Ensure CIWA-Ar done q2hrly at least initially for all patients commenced on regimen. Check BAC before commencing. Do not start CIWA-Ar or benzodiazepines until 6+ hours post last drink. Regularly review patient and adjust as per clinical judgement.
Do not give regular or PRN doses if patient is sedated. If multiple doses are not able to be given, review regular dosing schedule.
Special Cases
Seizures (current or past): Consider loading with benzodiazepines as for severe withdrawal
Alcohol Withdrawal Delirium: Needs ICU/HDU or 1:1 nursing
Adjunctive Medications for Severe Symptoms: In cases of delirium or severe agitation/psychosis poorly responsive to benzodiazepines, other agents may be considered after specialist consultation. Examples include low-dose antipsychotics (e.g., Haloperidol, Olanzapine). These are not first-line and require careful risk/benefit assessment.
General Notes: If total daily diazepam equivalent exceeds 80mg, contact specialist service (e.g. D&A CL service, Drug and Alcohol State Advisory Service (DASAS) - 1800 023 687)
Patient Selection Criteria
The following criteria should be met for a patient to be considered for an outpatient (ambulatory) detox.
Inclusion Criteria
- Age > 18-years-old.
- Has undertaken a comprehensive AOD assessment, has alcohol dependence, and is willing to engage in the detox process.
- Patient has up-to-date FBC, LFTs, EUCs, INR, and these have been reviewed by the AOD clinician.
- Mild to moderate alcohol withdrawal severity expected, defined by:
- Average or low risk on Prediction of Alcohol Withdrawal Severity Scale (PAWSS), OR a clear clinical rationale exists for proceeding despite a higher score.
- Patient’s average alcohol intake is ≤15 standard drinks per day.
- Patient agrees to daily review at the service.
- Patient has nominated a pharmacy or other suitable location (e.g. clinic or practice where medicines have been left) for DAILY pickup of medication, and the dispensing location has agreed.
- Patient has a reasonably safe home environment or supervision.
- Patient has reliable means for daily reviews (e.g., transport to review or clinician will go to patient).
- Patient has a reasonable plan for service engagement after detox (e.g., outpatient services, rehabilitation).
- There is no alcohol remaining in the house prior to detox commencing.
Exclusion Criteria (Contraindications)
- Medical or psychiatric contraindications, including but not limited to: a seizure disorder, prior or current Wernicke-Korsakoff syndrome, history of suicide attempts, cognitive impairment, or recurrent delirium.
- Major unmanaged hepatic or renal disease. If present, discussion with an addiction medicine specialist is required regarding regimen modification (e.g., using oxazepam instead of diazepam).
- Patient is on regular opioids, beta-blockers, or alpha-adrenergic acting agents (e.g., clonidine, prazosin) due to potential interactions and/or masking of alcohol withdrawal symptoms.
Example Daily Protocol
This is an example process for a structured outpatient detox program.
- All detoxes start on Monday, cease on Friday, and are organised the week prior.
- Scripts for the weaning regimen are written by the patient's GP or a service medical officer.
- Patient must present daily for review:
- Nursing staff perform a CIWA-Ar assessment in the AM before the first dose of the day.
- Nursing staff perform a brief delirium screen daily (e.g., 4AT screen).
- Nursing staff perform a breathalyser test (or if unavailable, an alternative screening method for recent alcohol consumption). All patients must have an undetectable BAL to qualify for further benzodiazepines.
- Basic observations are taken (HR, BP, RR, temperature).
- If all checks are satisfactory, staff will call the nominated pharmacy to authorise the dispensing of the next day's supply of medication.
- In the absence of complicating factors, reviews on days 4-5 may be via phone or video call.
- Medical Officer Review Triggers:
- Nursing staff should call the AOD medical officer if CIWA-Ar score is >20 or other complications arise.
- If any concerns arise (e.g., high CIWA-Ar score, positive BAL, signs of delirium), the patient should be referred to a medical officer for review and the detox protocol should be ceased.
- The medical officer should consider calling a specialist service (e.g., DASAS 1800 023 687) if withdrawal appears severe despite treatment.
- Top-up doses may be considered in rare circumstances via a separate, specific script.
Medication Regimen
Example Diazepam Regimen (Fixed-Dose):
A common approach is a 5-day fixed-dose weaning regimen. This must be adjusted based on clinical assessment. Staged, daily supply from a pharmacy is essential.
- Day 1: 10mg QID (four times a day)
- Day 2: 10mg TDS (three times a day)
- Day 3: 10mg BD (twice a day)
- Day 4: 5mg BD (twice a day)
- Day 5: 5mg Nocte (at night), then cease.
Ensure that in addition to the above patients receive thiamine 300mg oral tablets daily
Dosing Times:
A QID (four times a day) schedule can be challenging. While ideal times might be 0600, 1200, 1800, 2200, a more realistic schedule based on service opening hours might be:
09:00, 13:00, 18:00, 22:00
It is helpful to provide the patient with a pictorial or clearly written schedule of their dosing times.
When to Cease or Escalate Care
Situations Triggering Protocol to be Aborted
- Patient has a positive BAL (Blood Alcohol Level).
- Patient does not present for reviews or is not taking diazepam as directed (e.g., taking takeaway doses all at once).
- Use of other interacting substances (e.g., opioids, illicit drugs).
- Verbal abuse or violence towards staff.
- Oversedation despite the clinician decreasing doses.
Situations Triggering Presentation to Hospital
- Seizures
- Delirium
- Hallucinations
- Suicidality
- Other acute medical concerns
Calculate by Volume and ABV
Statewide D&A / Addiction Services
- ADIS (Alcohol and Drug Information Service): 1800 422 599 / (02) 9361 8000 (24/7)
- DASAS (Drug and Alcohol State Advisory Service): 1800 023 687 (24/7 line for remote advice from addiction specialists to regional, rural and remote NSW clinicians)
- Opioid Treatment Line: 1800 642 428 (M-F, 9:30am-5pm)
- Stimulant Treatment Line: 1800 101 188 (24/7)
- Quitline (Smoking Cessation): 13 78 48 (M-F, 8am-8pm; Sat, 9am-5pm)
- Family Drug Support Line: 1300 368 186 (24/7)
- Gambling Help (G-Line): 1800 633 635 (24/7)
NSW Local Health District (LHD) D&A Service Intake Lines
- Albury Wodonga Health Network: (02) 6058 1800
- Central Coast: (02) 4394 4880
- Far West: 08 8080 1554
- Hunter New England: 1300 660 059
- Illawarra Shoalhaven: 1300 652 226
- Mid North Coast: 1300 662 263
- Murrumbidgee: 1800 800 944
- Nepean Blue Mountains: 1300 661 050
- Northern NSW: (02) 6620 7608 (Lismore) / (02) 5506 7010 (Tweed Heads)
- Northern Sydney: 1300 889 788
- South Eastern Sydney: (02) 9332 8777 (Northern) / (02) 9113 2944 (Central)
- South Western Sydney: (02) 9616 8586
- Southern NSW: 1800 809 423
- Sydney: 1800 793 466
- Western NSW: 1300 887 000
- Western Sydney: (02) 9840 3355
General Mental Health
- Mental Health Helpline: 1800 011 511 (24/7 crisis support & referral)
- Lifeline: 13 11 14 (24/7 phone counselling)
- Suicide Call Back Service: 1300 659 467 (Crisis counselling for those at risk of suicide and/or their carers, and those bereaved by suicide)
- Kids Helpline: 1800 551 800 (Counselling for people aged 5-25)
- 13YARN: 13 92 76 (24/7 Aboriginal & Torres Strait Islander crisis support)
Sexual Health and Infectious Diseases
- Sexual Health Checkup: 1800 816 925 (Free sexual health check clinics, some vaccinations offered if relevant)
- Hepatitis Infoline: 1800 803 990 (Free information, support and referrals for people with hepatitis including referrals for support with hepatitis C eradication: see also www.hep.org.au)
Relationship Crisis / Domestic Violence
- 1800RESPECT: 1800 737 825 (24/7 national sexual assault, domestic and family violence counselling)
- MensLine Australia: 1300 789 978 (Provides free practical support, information or referral to men with relationship or violence problems including free phone and online counselling. See mensline.org.au)
- NSW Domestic Violence Line: 1800 656 463 (Free 24/7 support with domestic violence issues)
- NSW Sexual Violence Helpline: 1800 424 017(Free 24/7 access to trauma specialist counsellors)
Housing and Financial Instability
- Link2Home: 1800 152 152 (Provides support and information about local homelessness services in NSW)
- Financial Counselling Australia: 1300 007 007 (Provides free financial counselling and support)
About the Withdrawal Management Assistant
This application is a Progressive Web App (PWA) designed for clinical decision support, intended to assist healthcare professionals in managing alcohol and other substance withdrawal syndromes.
It provides quick access to summarised guidelines, interactive triage flowcharts, and common clinical calculators in a fast, offline-capable, and installable web app format.
Disclaimer
This application is intended for educational and informational purposes only.
It is an informal quality improvement project based on guidelines and operating procedures from various health districts. It is not a medical device and is not a substitute for professional clinical judgment, diagnosis, or treatment. The author bears no responsibility for decisions made using it.
All information, calculations, and recommendations generated by this tool must be independently verified by a qualified clinician before being used for patient care.
Copyright © Trent Koessler 2025.
All rights reserved. No part of this publication may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the publisher, except in the case of brief quotations embodied in critical reviews and certain other non-commercial uses permitted by copyright law.
Version
Current Version: